PROGNOSTIC IMPACT OF SERUM CXC CHEMOKINE LIGANDS 4 AND 7 ON MYELODYSPLASTIC SYNDROMES POST ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT

Yazar: DHAKAL, BINOD, WANG, TAO, HAAGENSON, MICHAEL, ZHU, FENLU, TAYLOR, CAROLYN, FENLU, SPELLMAN, STEPHEN R., VERNERIS, MICHAEL R., HSU, KATHARINE, FLEISCHHAUER, KATHARINA, LEE, STEPHANIE J., BOLON, YUNG-TSI, CARLSON, KAREN-SUE, NAZHA, AZIZ, SABER, WAEL
Yayımlandı Leuk Lymphoma (2020)

Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft-versus-host disease: low incidence of lower gastrointestinal tract disease

Yazar: Drobyski, William R., Szabo, Aniko, Zhu, Fenlu, Keever-Taylor, Carolyn, Hebert, Kyle M., Dunn, Renee, Yim, Sharon, Johnson, Bryon, D’Souza, Anita, Eapen, Mary, Fenske, Timothy S., Hari, Parameswaran, Hamadani, Mehdi, Horowitz, Mary M., Rizzo, J. Douglas, Saber, Wael, Shah, Nirav, Shaw, Bronwen, Pasquini, Marcelo
Yayımlandı Haematologica (2018)

A colitogenic memory CD4(+) T cell population mediates gastrointestinal graft-versus-host disease

Yazar: Zhou, Vivian, Agle, Kimberle, Chen, Xiao, Beres, Amy, Komorowski, Richard, Belle, Ludovic, Taylor, Carolyn, Zhu, Fenlu, Haribhai, Dipica, Williams, Calvin B., Verbsky, James, Blumenschein, Wendy, Sadekova, Svetlana, Bowman, Eddie, Ballantyne, Christie, Weaver, Casey, Serody, David A., Vincent, Benjamin, Serody, Jonathan, Cua, Daniel J., Drobyski, William R.
Yayımlandı J Clin Invest (2016)

Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation

Yazar: Chhabra, Saurabh, Visotcky, Alexis, Pasquini, Marcelo C., Zhu, Fenlu, Tang, Xiaoying, Zhang, Mei-Jie, Thompson, Robert, Abedin, Sameem, D’Souza, Anita, Dhakal, Binod, Drobyski, William R., Fenske, Timothy S., Jerkins, James H., Rizzo, J. Douglas, Runaas, Lyndsey, Saber, Wael, Shah, Nirav N., Shaw, Bronwen E., Horowitz, Mary M., Hari, Parameswaran N., Hamadani, Mehdi
Yayımlandı Biol Blood Marrow Transplant (2020)